110 related articles for article (PubMed ID: 1490508)
1. Nuclear DNA analysis: DNA heterogeneity in the monitoring of patients with locally advanced prostatic carcinoma.
al-Abadi H; Nagel R
Eur Urol; 1992; 22(4):303-10. PubMed ID: 1490508
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of ploidy and DNA-heterogeneity in the primary diagnosis and monitoring of patients with locally advanced prostatic carcinoma.
Nagel R; al Abadi H
Scand J Urol Nephrol Suppl; 1991; 138():83-92. PubMed ID: 1785025
[TBL] [Abstract][Full Text] [Related]
3. Nuclear DNA analysis: the relevance of ploidy, DNA heterogeneity and phases of the cell cycle in 329 patients with prostatic carcinoma. A study on a follow-up of eight years.
al-Abadi H; Nagel R
Urol Int; 1990; 45(6):350-5. PubMed ID: 2288053
[TBL] [Abstract][Full Text] [Related]
4. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
al-Abadi H; Nagel R
J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
[TBL] [Abstract][Full Text] [Related]
5. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
6. Treatment of locally advanced prostatic carcinoma with LHRH analogues: cytological, DNA-cytophotometrical, and clinical results.
Borgmann V; al-Abadi H; Nagel R
Am J Clin Oncol; 1988; 11 Suppl 1():S19-28. PubMed ID: 2968759
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of DNA ploidy and proliferative activity in urothelial carcinoma of the renal pelvis and ureter. A study on a follow-up period of 6 years.
Borgmann V; al-Abadi H; Nagel R
Urol Int; 1991; 47(1):7-11. PubMed ID: 1871915
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of nuclear DNA content in prostatic carcinoma.
Forsslund G; Esposti PL; Nilsson B; Zetterberg A
Cancer; 1992 Mar; 69(6):1432-9. PubMed ID: 1540880
[TBL] [Abstract][Full Text] [Related]
9. Ploidy level and tumor progression in prostatic carcinoma.
Zetterberg A; Forsslund G
Acta Oncol; 1991; 30(2):193-9. PubMed ID: 2029404
[TBL] [Abstract][Full Text] [Related]
10. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry.
Winkler HZ; Rainwater LM; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
Mayo Clin Proc; 1988 Feb; 63(2):103-12. PubMed ID: 3339904
[TBL] [Abstract][Full Text] [Related]
11. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of ploidy and proliferative activity of renal cell carcinoma.
Al-Abadi H; Nagel R
Eur Urol; 1988; 15(3-4):271-6. PubMed ID: 3215262
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
14. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
[TBL] [Abstract][Full Text] [Related]
15. Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer.
Pollack A; Zagars GK; el-Naggar AK; Terry NH
Urology; 1994 Nov; 44(5):711-8. PubMed ID: 7526527
[TBL] [Abstract][Full Text] [Related]
16. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy.
Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG
Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048
[TBL] [Abstract][Full Text] [Related]
17. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ
Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493
[TBL] [Abstract][Full Text] [Related]
18. Comparison of DNA ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the prostate: an image cytometric study.
Baretton GB; Vogt T; Blasenbreu S; Löhrs U
Hum Pathol; 1994 May; 25(5):506-13. PubMed ID: 8200645
[TBL] [Abstract][Full Text] [Related]
19. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
20. [Renal cell carcinoma: DNA cytometry and its clinical significance. An 8 year survival study].
al-Abadi H; Nagel R
Helv Chir Acta; 1991 Sep; 58(3):331-4. PubMed ID: 1769855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
